<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran J Neurol</journal-id><journal-id journal-id-type="iso-abbrev">Iran J Neurol</journal-id><journal-id journal-id-type="publisher-id">IJNL</journal-id><journal-title-group><journal-title>Iranian Journal of Neurology</journal-title></journal-title-group><issn pub-type="ppub">2008-384X</issn><issn pub-type="epub">2252-0058</issn><publisher><publisher-name>Tehran University of Medical Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24250843</article-id><article-id pub-id-type="pmc">3829225</article-id><article-id pub-id-type="publisher-id">IJNL-10-035</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>The effects of body mass index on the treatment of the patients with migraine headaches</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Afshinmajd</surname><given-names>Siamak</given-names></name><xref ref-type="aff" rid="AF0001">1</xref></contrib><contrib contrib-type="author"><name><surname>Davati</surname><given-names>Ali</given-names></name><xref ref-type="aff" rid="AF0002">2</xref></contrib><contrib contrib-type="author"><name><surname>Akbari</surname><given-names>Farnaz</given-names></name><xref ref-type="aff" rid="AF0003">3</xref></contrib></contrib-group><aff id="AF0001"><label>1</label>Department of Neurology, Shahed University, Tehran, Iran</aff><aff id="AF0002"><label>2</label>Department of Social Medicine, Shahed University, Tehran, Iran</aff><aff id="AF0003"><label>3</label>Shariati Hospital, Department of Neurology, Tehran University of Medical Sciences, Tehran, Iran</aff><author-notes><corresp id="cor1"><bold>Corresponding Author: Siamak Afshinmajd</bold>, Department of Neurology, Shahed University, Tehran, Iran. <bold>Email:</bold><email xlink:href="safshinmajd@yahoo.com">safshinmajd@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><year>2011</year></pub-date><volume>10</volume><issue>3-4</issue><fpage>35</fpage><lpage>38</lpage><history><date date-type="received"><day>07</day><month>2</month><year>2011</year></date><date date-type="accepted"><day>05</day><month>5</month><year>2011</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2011 Iranian Neurological Association, and Tehran University of Medical Sciences</copyright-statement><copyright-year>2011</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</license-p></license></permissions><abstract><sec id="st1"><title>Background</title><p>Migraine is a prevalent disease which is classified into two groups of migraine with aura and without aura. Eighteen percent of women and 6.5 percent of men in United States have migraine headache. Migraine headache is prevalent in all age groups but it usually subsides in adults above fifty. Migraine has many risk factors such as stress, light, tiredness, special foods and beverages. The aim of this study was the evaluation of the effects of body mass index (BMI) on the treatment of migraine headaches.</p></sec><sec id="st2"><title>Methods</title><p>All patients assigned to four groups according to their BMI. Patients with more than three attacks per month received nortriptyline and propranolol for eight weeks. The frequency, duration and severity of pain were measured by visual analogue scale (VAS) and behavioral rating scale (BRS-6) in regular intervals.</p></sec><sec id="st3"><title>Results</title><p>203 patients completed the study. 153(75%) subjects were women and 50(25%) were men. Mean age of patients was 30.5 &#x000b1; 7.1 years. Mean weight was 80.4 &#x000b1; 14.1 kg and mean height was 1.67 &#x000b1; 0.07 m. Pain frequency and duration showed statistically significant differences among four groups with better response in patients with lower BMI (P &#x0003c; 0.0001). VAS and BRS-6 scales showed statistically significant differences among four groups in favor of patients with lower BMI (P &#x0003c; 0.0001).</p></sec><sec id="st4"><title>Conclusion</title><p>This study showed that obesity has a direct influence on the treatment of migraine headaches. It could be recommended to patients to reduce their weight for better response to treatment. In addition, care should be taken about migraine drugs which make a tendency for increased appetite.</p></sec></abstract><kwd-group><kwd>Migraine</kwd><kwd>Body Mass Index</kwd><kwd>Visual Analogue Scale</kwd></kwd-group></article-meta></front><body><sec id="S0001"><title>Introduction</title><p>Migraine is a periodic, often pulsatile unilateral headache, which is common in all ranges of ages.<sup><xref ref-type="bibr" rid="CIT0001">1</xref>, <xref ref-type="bibr" rid="CIT0002">2</xref></sup> Migraine headaches usually begin in the early adulthood although it can begins as late as fifth decade of life.<sup><xref ref-type="bibr" rid="CIT0001">1</xref>, <xref ref-type="bibr" rid="CIT0003">3</xref>&#x02013;<xref ref-type="bibr" rid="CIT0005">5</xref></sup> There are two types of syndrome, migraine with aura and without aura. The ratio of these two types of migraine is 1:5.<sup><xref ref-type="bibr" rid="CIT0006">6</xref>&#x02013;<xref ref-type="bibr" rid="CIT0009">9</xref></sup> In genetic studies, a Mendelian pattern was not observed in both types of migraine but familial occurrence is common in both types and especially in patients with aura.<sup><xref ref-type="bibr" rid="CIT0010">10</xref>, <xref ref-type="bibr" rid="CIT0011">11</xref></sup> Migraine is a common disorder and prevalence of it is approximately 6.5 percent in men and 18 percent in women.</p><p>In many women, migraine attacks tend to occur in premenstrual period and in some women migraine attacks occur solely in this period.<sup><xref ref-type="bibr" rid="CIT0012">12</xref>, <xref ref-type="bibr" rid="CIT0013">13</xref></sup> Episodes of headaches usually persists 4&#x02013;72 hours and nausea, vomiting, photophobia, phonophobia and fatigue are common symptoms that are usually observed in this disorder.<sup><xref ref-type="bibr" rid="CIT0007">7</xref>, <xref ref-type="bibr" rid="CIT0014">14</xref>&#x02013;<xref ref-type="bibr" rid="CIT0017">17</xref></sup> Pain is usually severe and needs treatment with analgesics and sometimes bed rest is necessary. Migraines have many risk factors, some patients experience severe attacks after especial foods such as cheese, chocolate, onion or especial foods rich in tyramine. Alcohol, cigarette smoking, and sun exposure are other risk factors.<sup><xref ref-type="bibr" rid="CIT0018">18</xref>&#x02013;<xref ref-type="bibr" rid="CIT0024">24</xref></sup>
</p><p>Obesity is a serious problem in our life which is growing more and more specially in city dwellers. Obesity has lots of complications such as heart failure, sudden death, early fatigue ability and osteoarthritis.<sup><xref ref-type="bibr" rid="CIT0025">25</xref>&#x02013;<xref ref-type="bibr" rid="CIT0028">28</xref></sup> Many methods are used for migraine headaches treatment such as chemical drugs, psychotherapy, injection of botulinum toxin, behavioral modifications, psychotherapy, chiropractic, acupuncture and biofeedback techniques. Some of these treatments are not accepted by all experts but there is consensus upon drugs.<sup><xref ref-type="bibr" rid="CIT0022">22</xref>, <xref ref-type="bibr" rid="CIT0024">24</xref>, <xref ref-type="bibr" rid="CIT0029">29</xref>&#x02013;<xref ref-type="bibr" rid="CIT0032">32</xref></sup> Treatment are divided into two phases, acute treatment of pain and preventive treatment. In the first phase, we usually use analgesics (NSAIDS), serotonin agonists and ergots derivatives and in the second phase the most preferred drugs are beta blockers, tricyclic antidepressants and anticonvulsants.<sup><xref ref-type="bibr" rid="CIT0003">3</xref>, <xref ref-type="bibr" rid="CIT0030">30</xref>, <xref ref-type="bibr" rid="CIT0031">31</xref>, <xref ref-type="bibr" rid="CIT0033">33</xref>&#x02013;<xref ref-type="bibr" rid="CIT0035">35</xref></sup>
</p><p>Migraine is very important disease with high prevalence which makes many patients to spend a lot of time in bed for resting. Although there are many various treatments, some of them are not tolerated in all patients. Further investigation is recommended to find better options for the treatment of migraine headaches. In this study, we aimed to evaluate the effects of weight on the preventive treatment of migraine headaches.</p></sec><sec sec-type="materials|methods" id="S0002"><title>Materials and Methods</title><p>This was a prospective experimental study conducted on 203 patients who were referred for evaluation of headache to the neurology clinic in the period from 2009 to 2010. All cases were selected randomly. Subjects were categorized in four groups according to their body mass index (BMI), &#x0003c; 24.9, 24.9-29, 29-34.9 and &#x0003e;35. After the description of methods and aims of study all patients who had more than 3 episodes of migraine headaches each month and voluntarily asked for preventing treatment were selected for study.</p><p>All patients were adults between 18 to 45 years old who had migraine headaches according to International headache society criteria (IHS). Visual analogue scale (VAS) and 6-point behavioral rating scale (BRS-6) were two standard international scales which were used for evaluation of the severity of pain. BRS-6 is a standard score for pain based on clinical symptoms which is divided from 0 to 5. Higher scores show more severe pain.</p><p>All patients were evaluated for the frequency, duration and severity of pain in the beginning of study and at the end of 4<sup>th</sup>, 6<sup>th</sup> and 8<sup>th</sup> weeks. Selected patients were treated with nortriptyline 0.6 mg/kg/d and propranolol 1mg/kg/d. Dosage was increased gradually over four weeks from the beginning of study to the end of 4<sup>th</sup> week. If there was any drug reaction or complication, treatment was discontinued. Individuals who had any contraindication for use of these drugs were not included in this study. Data were recorded an analyzed with SPSS software version 16. This study was a dissertation supported by Shahed University. Written informed consent was obtained from all participants.</p></sec><sec sec-type="results" id="S0003"><title>Results</title><p>There were 153 (75%) women and 50 (25%) men. Mean age of the patients was 30.5 &#x000b1; 7.1 years ranged from 15 to 45 years. Weight, height and BMI of participants were 80.4 &#x000b1; 14.1 kg, 1.67 &#x000b1; 0.07 meter and 28.5 &#x000b1; 4.1, respectively.</p><p>Pain frequency decreased from 8.1 &#x000b1; 2.3 attacks per month at baseline to 2.9 &#x000b1; 2.6 attacks per month in 8th week. Pain duration decreased from 16.1 &#x000b1; 6.1 hour at baseline to 11.7 &#x000b1; 5.2, 7.2 &#x000b1; 5.8 and 6.6 &#x000b1; 5.8 in 4th, 6th and 8th weeks, respectively. VAS also showed a decreasing pattern from 73.3 &#x000b1; 15.2 mm in 1st week to 56.8 &#x000b1; 16.2 mm, 40.3 &#x000b1; 20.9 mm and 32.7 &#x000b1; 23.9 mm in 4th, 6th and 8th weeks, respectively. BRS-6 was 3.43 &#x000b1; 1.04 in 1st week. It reduced to 2.72 &#x000b1; 1.04 in 4th week, 1.84 &#x000b1; 1.07 in 6th week and 1.40 &#x000b1; 1.20 in 8th week.</p><p>Different demographic characteristic of patients, pain duration, frequency and severity of pain measured with VAS and BRS-6 scales are summarized in <xref ref-type="table" rid="T0001">Tables 1</xref> to <xref ref-type="table" rid="T0003">3</xref>. <xref ref-type="fig" rid="F0001">Diagrams 1</xref> and <xref ref-type="fig" rid="F0002">2</xref> show VAS and BRS-6 values in BMI groups.
</p><fig id="F0001" position="float"><label>Figure 1</label><caption><p>Variations of visual analogue scale in different body mass index groups during the weeks of intervention</p></caption><graphic xlink:href="IJNL-10-035-g001"/></fig><fig id="F0002" position="float"><label>Figure 2</label><caption><p>Behavioral rating scale (BRS) in different body mass index groups during eight weeks of intervention</p></caption><graphic xlink:href="IJNL-10-035-g002"/></fig><table-wrap id="T0001" position="float"><label>Table 1</label><caption><p>Pain frequency and duration in different body mass index groups throughout the study period</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" valign="top" colspan="1">BMI</th><th align="center" colspan="2" rowspan="1">Pain frequency (attack/month)</th><th align="center" colspan="4" rowspan="1">Pain duration (hours)</th></tr><tr><th align="center" rowspan="1" colspan="1">1st day</th><th align="center" rowspan="1" colspan="1">8th week</th><th align="center" rowspan="1" colspan="1">1st day</th><th align="center" rowspan="1" colspan="1">4th week</th><th align="center" rowspan="1" colspan="1">6th week</th><th align="center" rowspan="1" colspan="1">8th week</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">&#x0003c; 25 (n = 61)</td><td align="center" rowspan="1" colspan="1">8.45 &#x000b1; 2.21</td><td align="center" rowspan="1" colspan="1">1.03 &#x000b1; 1.36</td><td align="center" rowspan="1" colspan="1">14.67 &#x000b1; 6.15</td><td align="center" rowspan="1" colspan="1">9.40 &#x000b1; 3.95</td><td align="center" rowspan="1" colspan="1">3.24 &#x000b1; 3.19</td><td align="center" rowspan="1" colspan="1">2.49 &#x000b1; 2.93</td></tr><tr><td align="left" rowspan="1" colspan="1">25-29.9 (n = 60)</td><td align="center" rowspan="1" colspan="1">8.51 &#x000b1; 2.25</td><td align="center" rowspan="1" colspan="1">2.36 &#x000b1; 1.40</td><td align="center" rowspan="1" colspan="1">15.20 &#x000b1; 5.97</td><td align="center" rowspan="1" colspan="1">10.78 &#x000b1; 4.29</td><td align="center" rowspan="1" colspan="1">5.65 &#x000b1; 3.25</td><td align="center" rowspan="1" colspan="1">4.78 &#x000b1; 2.93</td></tr><tr><td align="left" rowspan="1" colspan="1">30-34.9 (n = 65)</td><td align="center" rowspan="1" colspan="1">7.96 &#x000b1; 2.52</td><td align="center" rowspan="1" colspan="1">4.69 &#x000b1; 2.78</td><td align="center" rowspan="1" colspan="1">17.50 &#x000b1; 5.97</td><td align="center" rowspan="1" colspan="1">13.43 &#x000b1; 5.40</td><td align="center" rowspan="1" colspan="1">10.32 &#x000b1; 5.78</td><td align="center" rowspan="1" colspan="1">10.10 &#x000b1; 5.78</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003e;35 (n = 17)</td><td align="center" rowspan="1" colspan="1">6.70 &#x000b1; 2.56</td><td align="center" rowspan="1" colspan="1">5.23 &#x000b1; 3.09</td><td align="center" rowspan="1" colspan="1">19.52 &#x000b1; 4.81</td><td align="center" rowspan="1" colspan="1">17.70 &#x000b1; 5.25</td><td align="center" rowspan="1" colspan="1">15.76 &#x000b1; 6.48</td><td align="center" rowspan="1" colspan="1">14.70 &#x000b1; 6.69</td></tr><tr><td align="left" rowspan="1" colspan="1">P-value</td><td align="center" rowspan="1" colspan="1">0.29</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" rowspan="1" colspan="1">0.003</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr></tbody></table><table-wrap-foot><fn><p>Data are presented as mean &#x000b1; standard deviation</p></fn></table-wrap-foot></table-wrap><table-wrap id="T0002" position="float"><label>Table 2</label><caption><p>Visual analogue scale variations in different groups in different weeks of study</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">BMI</th><th align="center" rowspan="1" colspan="1">1st Week (mm)</th><th align="center" rowspan="1" colspan="1">4th Week (mm)</th><th align="center" rowspan="1" colspan="1">6th Week (mm)</th><th align="center" rowspan="1" colspan="1">8th Week (mm)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">&#x0003c;25 (n = 61)</td><td align="center" rowspan="1" colspan="1">71.04 &#x000b1; 15.81</td><td align="center" rowspan="1" colspan="1">49.32 &#x000b1; 13.91</td><td align="center" rowspan="1" colspan="1">23.49 &#x000b1; 13.13</td><td align="center" rowspan="1" colspan="1">11.32 &#x000b1; 12.58</td></tr><tr><td align="left" rowspan="1" colspan="1">25-29.9 (n = 60)</td><td align="center" rowspan="1" colspan="1">70.33 &#x000b1; 15.96</td><td align="center" rowspan="1" colspan="1">51.78 &#x000b1; 15.00</td><td align="center" rowspan="1" colspan="1">33.88 &#x000b1; 14.11</td><td align="center" rowspan="1" colspan="1">24.76 &#x000b1; 12.89</td></tr><tr><td align="left" rowspan="1" colspan="1">30-34.9 (n = 65)</td><td align="center" rowspan="1" colspan="1">76.00 &#x000b1; 13.84</td><td align="center" rowspan="1" colspan="1">63.69 &#x000b1; 13.61</td><td align="center" rowspan="1" colspan="1">54.00 &#x000b1; 15.41</td><td align="center" rowspan="1" colspan="1">50.47 &#x000b1; 16.36</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003e;35 (n = 17)</td><td align="center" rowspan="1" colspan="1">82.64 &#x000b1; 11.19</td><td align="center" rowspan="1" colspan="1">75.00 &#x000b1; 12.74</td><td align="center" rowspan="1" colspan="1">71.47 &#x000b1; 13.89</td><td align="center" rowspan="1" colspan="1">70.52 &#x000b1; 14.37</td></tr><tr><td align="left" rowspan="1" colspan="1">P-value</td><td align="center" rowspan="1" colspan="1">0.007</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr></tbody></table><table-wrap-foot><fn><p>Data are presented as mean &#x000b1; standard deviation</p></fn></table-wrap-foot></table-wrap><table-wrap id="T0003" position="float"><label>Table 3</label><caption><p>Behavioral rating scale in different weeks of study in four groups of body mass index</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">BMI</th><th align="center" rowspan="1" colspan="1">BRS6 base</th><th align="center" rowspan="1" colspan="1">BRS6 after 4 week</th><th align="center" rowspan="1" colspan="1">BRS6 after 6 week</th><th align="center" rowspan="1" colspan="1">BRS6 after 8 week</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">&#x0003c;25 (n = 61)</td><td align="center" rowspan="1" colspan="1">3.31 &#x000b1; 1.07</td><td align="center" rowspan="1" colspan="1">2.47 &#x000b1; 1.01</td><td align="center" rowspan="1" colspan="1">1.29 &#x000b1; 0.97</td><td align="center" rowspan="1" colspan="1">0.44 &#x000b1; 0.71</td></tr><tr><td align="left" rowspan="1" colspan="1">25-29.9 (n = 60)</td><td align="center" rowspan="1" colspan="1">3.20 &#x000b1; 1.05</td><td align="center" rowspan="1" colspan="1">2.43 &#x000b1; 0.98</td><td align="center" rowspan="1" colspan="1">1.53 &#x000b1; 0.85</td><td align="center" rowspan="1" colspan="1">1.06 &#x000b1; 0.73</td></tr><tr><td align="left" rowspan="1" colspan="1">30-34.9 (n = 65)</td><td align="center" rowspan="1" colspan="1">3.61 &#x000b1; 1.01</td><td align="center" rowspan="1" colspan="1">3.01 &#x000b1; 1.02</td><td align="center" rowspan="1" colspan="1">2.26 &#x000b1; 0.90</td><td align="center" rowspan="1" colspan="1">2.15 &#x000b1; 0.98</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003e;35 (n = 17)</td><td align="center" rowspan="1" colspan="1">4.00 &#x000b1; 0.79</td><td align="center" rowspan="1" colspan="1">3.58 &#x000b1; 0.87</td><td align="center" rowspan="1" colspan="1">3.29 &#x000b1; 0.84</td><td align="center" rowspan="1" colspan="1">3.23 &#x000b1; 0.83</td></tr><tr><td align="left" rowspan="1" colspan="1">P-value</td><td align="center" rowspan="1" colspan="1">0.012</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr></tbody></table><table-wrap-foot><fn><p>Data are presented as mean &#x000b1; standard deviation</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion" id="S0004"><title>Discussion</title><p>The aim of this study was to evaluate the effects of BMI on the treatment of migraine headaches. As mentioned earlier, all patients were classified in four groups according to their BMI, and all were treated with the similar dosage of drugs. Age, height and weight were different in all four groups and increased with different BMI in different groups.</p><p>The mean frequency of pain was similar in all groups at the beginning but there was significant difference at the end of study. The mean duration of pain had significant difference in all groups at the beginning and at the end of 8<sup>th</sup> week. Mean VAS score did not show statistically significant difference between BMI groups at the beginning. However, the difference was statistically significant at the end of the study in favor of better response to treatment in lower BMI. BRS-6 score showed similar pattern.</p><p>In spite of direct influence of BMI on pain duration, it had no influence on pain frequency. However, comparing the influence of treatment on BMI in different groups showed that both frequency and duration had better outcome in patients with lower BMI. The findings of this study were in agreement with studies by Bigal et al.<sup><xref ref-type="bibr" rid="CIT0036">36</xref></sup> and Lipton et al.<sup><xref ref-type="bibr" rid="CIT0014">14</xref></sup> because their studies showed association between BMI and migraine headache, although these studies had different methods.</p><p>The findings of this study did not support Mattsson<sup><xref ref-type="bibr" rid="CIT0037">37</xref></sup> and Tietjen et al.<sup><xref ref-type="bibr" rid="CIT0038">38</xref></sup> which did not find direct influence of BMI on migraine headaches. The mechanism by which obesity affects on migraine or its treatment is unknown but mechanism that influence on body weight may simultaneously influence on migraine. Lower activity of sympathetic and higher activity of parasympathetic systems and secretion of special neuropeptides such as neuropeptide Y or melanocortins might be common factors.</p></sec><sec sec-type="conclusion" id="S0005"><title>Conclusion</title><p>This study showed that obesity has a direct influence on the treatment of migraine headaches. Treatment of migraine had direct association with BMI increments. Consequently, it should be recommended to patients to reduce their weight for better response to the treatment. In addition, physicians must be careful about migraine drugs which make a tendency for increased appetite.</p></sec></body><back><sec id="S0006"><title>Conflict of interest</title><p>The authors have no conflict of interest.</p></sec><ref-list><title>References</title><ref id="CIT0001"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigal</surname><given-names>ME</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name></person-group><article-title>Migraine at all ages</article-title><source>Curr Pain Headache Rep</source><year>2006</year><volume>10</volume><fpage>207</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">18778575</pub-id></element-citation></ref><ref id="CIT0002"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elrington</surname><given-names>G</given-names></name></person-group><article-title>Migraine: diagnosis and management</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2002</year><volume>72</volume><fpage>ii10</fpage><lpage>ii5</lpage><pub-id pub-id-type="pmid">12122196</pub-id></element-citation></ref><ref id="CIT0003"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dodick</surname><given-names>DW</given-names></name><name><surname>Silberstein</surname><given-names>SD</given-names></name></person-group><article-title>Migraine prevention</article-title><source>Pract Neurol</source><year>2007</year><volume>7</volume><fpage>383</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">18024778</pub-id></element-citation></ref><ref id="CIT0004"><label>4</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Raskin</surname><given-names>NH</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Kasper</surname><given-names>Dl</given-names></name><name><surname>Fauci</surname><given-names>AS</given-names></name><name><surname>Longo</surname><given-names>DL</given-names></name></person-group><article-title>Headache</article-title><source>Harrison's principles of internal medicine</source><year>2005</year><edition>16th ed</edition><publisher-loc>New York</publisher-loc><publisher-name>McGraw-Hill</publisher-name><fpage>85</fpage><lpage>94</lpage></element-citation></ref><ref id="CIT0005"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silberstein</surname><given-names>SD</given-names></name></person-group><article-title>Migraine</article-title><source>Lancet</source><year>2004</year><volume>363</volume><fpage>381</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">15070571</pub-id></element-citation></ref><ref id="CIT0006"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horev</surname><given-names>A</given-names></name><name><surname>Wirguin</surname><given-names>I</given-names></name><name><surname>Lantsberg</surname><given-names>L</given-names></name><etal/></person-group><article-title>A high incidence of migraine with aura among morbidly obese women</article-title><source>Headache</source><year>2005</year><volume>45</volume><fpage>936</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15985113</pub-id></element-citation></ref><ref id="CIT0007"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipton</surname><given-names>RB</given-names></name><name><surname>Bigal</surname><given-names>ME</given-names></name><name><surname>Steiner</surname><given-names>TJ</given-names></name><etal/></person-group><article-title>Classification of primary headaches</article-title><source>Neurology</source><year>2004</year><volume>63</volume><fpage>427</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">15304572</pub-id></element-citation></ref><ref id="CIT0008"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pakalnis</surname><given-names>A</given-names></name><name><surname>Gladstein</surname><given-names>J</given-names></name></person-group><article-title>Headaches and hormones</article-title><source>Semin Pediatr Neurol</source><year>2010</year><volume>17</volume><fpage>100</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">20541101</pub-id></element-citation></ref><ref id="CIT0009"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rapoport</surname><given-names>AM</given-names></name><name><surname>Bigal</surname><given-names>ME</given-names></name></person-group><article-title>The clinical spectrum of migraine</article-title><source>Compr Ther</source><year>2003</year><volume>29</volume><fpage>35</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">12701341</pub-id></element-citation></ref><ref id="CIT0010"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>MB</given-names></name></person-group><article-title>Genetics in primary headaches</article-title><source>J Headache Pain</source><year>2007</year><volume>8</volume><fpage>190</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">17563838</pub-id></element-citation></ref><ref id="CIT0011"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez</surname><given-names>F</given-names></name><name><surname>Colson</surname><given-names>NJ</given-names></name><name><surname>Griffiths</surname><given-names>LR</given-names></name></person-group><article-title>Pharmacogenetics of migraine: genetic variants and their potential role in migraine therapy</article-title><source>Pharmacogenomics</source><year>2007</year><volume>8</volume><fpage>609</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">17559350</pub-id></element-citation></ref><ref id="CIT0012"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teepker</surname><given-names>M</given-names></name><name><surname>Peters</surname><given-names>M</given-names></name><name><surname>Kundermann</surname><given-names>B</given-names></name><etal/></person-group><article-title>The effects of oral contraceptives on detection and pain thresholds as well as headache intensity during menstrual cycle in migraine</article-title><source>Headache</source><year>2011</year><volume>51</volume><fpage>92</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">20946429</pub-id></element-citation></ref><ref id="CIT0013"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuda</surname><given-names>K</given-names></name></person-group><article-title>Role of estrogen and endothelium in migraine in young women</article-title><source>Stroke</source><year>2009</year><volume>40</volume><fpage>e705</fpage><pub-id pub-id-type="pmid">19892993</pub-id></element-citation></ref><ref id="CIT0014"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipton</surname><given-names>RB</given-names></name><name><surname>Stewart</surname><given-names>WF</given-names></name><name><surname>von Korff</surname><given-names>M</given-names></name></person-group><article-title>Burden of migraine: societal costs and therapeutic opportunities</article-title><source>Neurology</source><year>1997</year><volume>48</volume><fpage>4</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9008485</pub-id></element-citation></ref><ref id="CIT0015"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipton</surname><given-names>RB</given-names></name><name><surname>Scher</surname><given-names>AI</given-names></name><name><surname>Kolodner</surname><given-names>K</given-names></name><etal/></person-group><article-title>Migraine in the United States: epidemiology and patterns of health care use</article-title><source>Neurology</source><year>2002</year><volume>58</volume><fpage>885</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">11914403</pub-id></element-citation></ref><ref id="CIT0016"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogawski</surname><given-names>MA</given-names></name></person-group><article-title>Common Pathophysiologic Mechanisms in Migraine and Epilepsy</article-title><source>Arch Neurol</source><year>2008</year><volume>65</volume><fpage>709</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">18541791</pub-id></element-citation></ref><ref id="CIT0017"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>T-RKR</surname><given-names>U</given-names></name><name><surname>KOER</surname><given-names>A</given-names></name><name><surname>L-LECI</surname><given-names>A</given-names></name><etal/></person-group><article-title>Prevalence and characteristics of migraine in women of reproductive age in Istanbul, Turkey: A population based survey</article-title><source>Tohoku J Exp Med</source><year>2005</year><volume>206</volume><fpage>51</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15802875</pub-id></element-citation></ref><ref id="CIT0018"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartleson</surname><given-names>JD</given-names></name><name><surname>Cutrer</surname><given-names>FM</given-names></name></person-group><article-title>Migraine update. Diagnosis and treatment</article-title><source>Minn Med</source><year>2010</year><volume>93</volume><fpage>36</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">20572569</pub-id></element-citation></ref><ref id="CIT0019"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigal</surname><given-names>ME</given-names></name><name><surname>Lipton</surname><given-names>RB</given-names></name></person-group><article-title>Overview on the prevalence and impact of migraine</article-title><source>J Headache Pain</source><year>2004</year><volume>5</volume><fpage>88</fpage><lpage>91</lpage></element-citation></ref><ref id="CIT0020"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabricius</surname><given-names>M</given-names></name><name><surname>Fuhr</surname><given-names>S</given-names></name><name><surname>Bhatia</surname><given-names>R</given-names></name><etal/></person-group><article-title>Cortical spreading depression and peri-infarct depolarization in acutely injured human cerebral cortex</article-title><source>Brain</source><year>2006</year><volume>129</volume><fpage>778</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">16364954</pub-id></element-citation></ref><ref id="CIT0021"><label>21</label><element-citation publication-type="journal"><collab>Headache Classification Subcommittee of the International Headache Society</collab><article-title>The international classification of headache disorders</article-title><source>Cephalalgia</source><year>2004</year><volume>24</volume><fpage>9</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">14979299</pub-id></element-citation></ref><ref id="CIT0022"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holroyd</surname><given-names>KA</given-names></name><name><surname>Cottrell</surname><given-names>CK</given-names></name><name><surname>O'Donnell</surname><given-names>FJ</given-names></name><etal/></person-group><article-title>Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial</article-title><source>BMJ</source><year>2010</year><volume>29</volume><fpage>341</fpage></element-citation></ref><ref id="CIT0023"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwasaki</surname><given-names>Y</given-names></name><name><surname>Ikeda</surname><given-names>K</given-names></name></person-group><article-title>Obesity and migraine: a population study</article-title><source>Neurology</source><year>2007</year><volume>68</volume><fpage>241</fpage><pub-id pub-id-type="pmid">17224585</pub-id></element-citation></ref><ref id="CIT0024"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szyszkowicz</surname><given-names>M</given-names></name><name><surname>Kaplan</surname><given-names>GG</given-names></name><name><surname>Grafstein</surname><given-names>E</given-names></name><etal/></person-group><article-title>Emergency department visits for migraine and headache: a multi-city study</article-title><source>Int J Occup Med Environ Health</source><year>2009</year><volume>22</volume><fpage>235</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">19819836</pub-id></element-citation></ref><ref id="CIT0025"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maggioni</surname><given-names>F</given-names></name><name><surname>Ruffatti</surname><given-names>S</given-names></name><name><surname>Dainese</surname><given-names>F</given-names></name><etal/></person-group><article-title>Weight variations in the prophylactic therapy of primary headaches: 6-month follow-up</article-title><source>J Headache Pain</source><year>2005</year><volume>6</volume><fpage>322</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">16362700</pub-id></element-citation></ref><ref id="CIT0026"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bond</surname><given-names>DS</given-names></name><name><surname>Roth</surname><given-names>J</given-names></name><name><surname>Nash</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Migraine and obesity: epidemiology, possible mechanisms and the potential role of weight loss treatment</article-title><source>Obes Rev</source><year>2011</year><volume>12</volume><fpage>e362</fpage><lpage>e371</lpage><pub-id pub-id-type="pmid">20673279</pub-id></element-citation></ref><ref id="CIT0027"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterlin</surname><given-names>BL</given-names></name><name><surname>Rapoport</surname><given-names>AM</given-names></name><name><surname>Kurth</surname><given-names>T</given-names></name></person-group><article-title>Migraine and obesity: epidemiology, mechanisms, and implications</article-title><source>Headache</source><year>2010</year><volume>50</volume><fpage>631</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">19845784</pub-id></element-citation></ref><ref id="CIT0028"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ray</surname><given-names>ST</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name></person-group><article-title>Migraine and obesity: cause or effect?</article-title><source>Headache</source><year>2010</year><volume>50</volume><fpage>326</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">19804397</pub-id></element-citation></ref><ref id="CIT0029"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullally</surname><given-names>WJ</given-names></name><name><surname>Hall</surname><given-names>K</given-names></name><name><surname>Goldstein</surname><given-names>R</given-names></name></person-group><article-title>Efficacy of biofeedback in the treatment of migraine and tension type headaches</article-title><source>Pain Physician</source><year>2009</year><volume>12</volume><fpage>1005</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">19935987</pub-id></element-citation></ref><ref id="CIT0030"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinberg</surname><given-names>J</given-names></name></person-group><article-title>Anticonvulsant medications for migraine prevention</article-title><source>Am Fam Physician</source><year>2005</year><volume>71</volume><fpage>1699</fpage><lpage>700</lpage><pub-id pub-id-type="pmid">15887447</pub-id></element-citation></ref><ref id="CIT0031"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vikelis</surname><given-names>M</given-names></name><name><surname>Rapoport</surname><given-names>AM</given-names></name></person-group><article-title>Role of antiepileptic drugs as preventive agents for migraine</article-title><source>CNS Drugs</source><year>2010</year><volume>24</volume><fpage>21</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">20030417</pub-id></element-citation></ref><ref id="CIT0032"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoppe</surname><given-names>A</given-names></name><name><surname>Weidenhammer</surname><given-names>W</given-names></name><name><surname>Wagenpfeil</surname><given-names>S</given-names></name><etal/></person-group><article-title>Correlations of headache diary parameters, quality of life and disability scales</article-title><source>Headache</source><year>2009</year><volume>49</volume><fpage>868</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">19438730</pub-id></element-citation></ref><ref id="CIT0033"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>W</given-names></name><name><surname>Herzog</surname><given-names>B</given-names></name><name><surname>Muhlig</surname><given-names>S</given-names></name><etal/></person-group><article-title>Pharmaceutical care for migraine and headache patients: a community-based, randomized intervention</article-title><source>Ann Pharmacother</source><year>2008</year><volume>42</volume><fpage>1804</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">19001531</pub-id></element-citation></ref><ref id="CIT0034"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silberstein</surname><given-names>SD</given-names></name><name><surname>Dodick</surname><given-names>D</given-names></name><name><surname>Freitag</surname><given-names>F</given-names></name><name><surname>Pearlman</surname><given-names>SH</given-names></name><name><surname>Hahn</surname><given-names>SR</given-names></name><name><surname>Scher</surname><given-names>AI</given-names></name><etal/></person-group><article-title>Pharmacological approaches to managing migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapy</article-title><source>Headache</source><year>2007</year><volume>47</volume><fpage>585</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">17445108</pub-id></element-citation></ref><ref id="CIT0035"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>D</given-names></name><name><surname>Ashwal</surname><given-names>S</given-names></name><name><surname>Hershey</surname><given-names>A</given-names></name><etal/></person-group><article-title>Pharmacological treatment of migraine headache in children and adolescents</article-title><source>Neurology</source><year>2004</year><volume>63</volume><fpage>2215</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">15623677</pub-id></element-citation></ref><ref id="CIT0036"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigal</surname><given-names>ME</given-names></name><name><surname>Tsang</surname><given-names>A</given-names></name><name><surname>Loder</surname><given-names>E</given-names></name><etal/></person-group><article-title>Body mass index and episodic headaches: a population-based study</article-title><source>Arch Intern Med</source><year>2007</year><volume>167</volume><fpage>1964</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">17923596</pub-id></element-citation></ref><ref id="CIT0037"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattsson</surname><given-names>P</given-names></name></person-group><article-title>Migraine headache and obesity in women aged 40-74 years: a population-based study</article-title><source>Cephalalgia</source><year>2007</year><volume>27</volume><fpage>877</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">17635528</pub-id></element-citation></ref><ref id="CIT0038"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tietjen</surname><given-names>GE</given-names></name><name><surname>Peterlin</surname><given-names>BL</given-names></name><name><surname>Brandes</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Depression and anxiety: effect on the migraine-obesity relationship</article-title><source>Headache</source><year>2007</year><volume>47</volume><fpage>866</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">17578537</pub-id></element-citation></ref></ref-list></back></article>